Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “United Kingdom”

VertiGreens Investigating the Effects of Iron Biofortification of Microgreens on Iron Status in WomenCompleted
NCT06972927NAUpdated Aug 20, 2026
Sponsor: University of Aberdeen
Iron Biomarkers/Status
United Kingdom
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3Recruiting
NCT05614739Phase 1Updated Aug 20, 2026
Sponsor: Eli Lilly and Company
Urinary Bladder Neoplasms · Neoplasm Metastasis · Ureteral Neoplasms
United States, Australia, Canada, China, France +9 more
A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)Active Not Recruiting
NCT06924970Phase 2Updated Aug 20, 2026
Sponsor: Agios Pharmaceuticals, Inc.
Sickle Cell Disease
United States, Belgium, Canada, France, Ireland +2 more
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With BronchiectasisRecruiting
NCT06872892Phase 3Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Bronchiectasis
United States, Argentina, Australia, Austria, Belgium +40 more
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic DiseasesRecruiting
NCT06806592Phase 3Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Interstitial Lung Diseases · Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
United States, Australia, Austria, China, France +11 more
Vorasidenib Maintenance for IDH Mutant AstrocytomaRecruiting
NCT06809322Phase 3Updated Aug 20, 2026
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
IDH-mutant Grade 2 or 3 Astrocytoma
Austria, Belgium, Czechia, France, Germany +5 more
Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)Completed
NCT03785964Phase 3Updated Aug 20, 2026
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Desmoid Tumor · Aggressive Fibromatosis
United States, Belgium, Canada, Germany, Italy +2 more
Iptacopan in Patients With ANCA Associated VasculitisActive Not Recruiting
NCT06388941Phase 2Updated Aug 20, 2026
Sponsor: Novartis Pharmaceuticals
Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis
United States, Argentina, Australia, Austria, Belgium +10 more
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)Recruiting
NCT07220083Phase 3Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Focal Segmental Glomerulosclerosis
United States, Argentina, Australia, Belgium, Brazil +35 more
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting
NCT00271180N/AUpdated Aug 20, 2026
Sponsor: Medtronic
Arrhythmia · Bradycardia · Heart Failure · Sinus Tachycardia
United States, Australia, Austria, Belgium, Canada +30 more
A Study to Learn About How Well BAY 3401016 Works in Adults With Alport SyndromeRecruiting
NCT07211685Phase 2Updated Aug 20, 2026
Sponsor: Bayer
Alport Syndrome
United States, Argentina, Canada, China, Czechia +10 more
Audit of Targeted Sentinel Node Biopsy (TSNB) in Patients With Limited Nodal Disease Undergoing Primary SurgeryRecruiting
NCT07085442N/AUpdated Aug 20, 2026
Sponsor: University Hospitals of Derby and Burton NHS Foundation Trust
Breast Cancer · Axillary Lymph Nodes Dissection · Axillary Metastases · Sentinel Lymph Node Biopsy (SLNB)
United Kingdom
A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or OverweightRecruiting
NCT07662122Phase 2Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Obesity · Overweight
United States, Australia, Canada, China, New Zealand +1 more
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]Recruiting
NCT06422143Phase 3Updated Aug 20, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer · NSCLC
United States, Argentina, Austria, Brazil, Canada +21 more
A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell CarcinomaNot Yet Recruiting
NCT07768189Phase 3Updated Aug 20, 2026
Sponsor: Corbus Pharmaceuticals Inc.
Oropharyngeal Carcinoma (OPC)
United States, Austria, United Kingdom
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate CancerRecruiting
NCT06800313Phase 1, Phase 2Updated Aug 20, 2026
Sponsor: Janssen Research & Development, LLC
Metastatic Prostate Cancer
United States, United Kingdom
A Study of Annual Doses of MK-1406/CD388 in Healthy Adults (MK-1406-006/CD388.SQ.2.07)Active Not Recruiting
NCT07225959Phase 2Updated Aug 20, 2026
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Healthy Participants
United States, United Kingdom
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk AdultsCompleted
NCT06067230Phase 3Updated Aug 20, 2026
Sponsor: ModernaTX, Inc.
Respiratory Syncytial Virus
United States, Canada, Puerto Rico, United Kingdom
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)Active Not Recruiting
NCT04886804Phase 1Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Neoplasm Metastasis · Non-Small Cell Lung Cancer
United States, Australia, Austria, Belgium, China +13 more
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)Active Not Recruiting
NCT04497844Phase 3Updated Aug 20, 2026
Sponsor: Janssen Research & Development, LLC
Metastatic Castration-sensitive Prostate Cancer
United States, Argentina, Australia, Belarus, Belgium +28 more
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes MellitusNot Yet Recruiting
NCT07776509Phase 3Updated Aug 20, 2026
Sponsor: AstraZeneca
Obesity or Overweight · Weight-Related Comorbidity · With/Without Diabetes Mellitus, Type 2
United States, Argentina, Brazil, Canada, China +6 more
UK SMA Patient RegistryRecruiting
NCT04292574N/AUpdated Aug 20, 2026
Sponsor: Newcastle University
Spinal Muscular Atrophy · SMA
United Kingdom
Brivekimig for the Treatment of Moderate to Severe Hidradenitis SuppurativaRecruiting
NCT07170917Phase 2Updated Aug 20, 2026
Sponsor: Sanofi
Hidradenitis Suppurativa
United States, Australia, Canada, Chile, China +14 more
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple MyelomaRecruiting
NCT04910568Phase 1Updated Aug 20, 2026
Sponsor: Genentech, Inc.
Multiple Myeloma
United States, Australia, Canada, Czechia, Denmark +8 more
A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistaminesActive Not Recruiting
NCT05976243Phase 3Updated Aug 20, 2026
Sponsor: Novartis Pharmaceuticals
Chronic Inducible Urticaria
United States, Argentina, Australia, Brazil, Canada +23 more

Previous page Next page